Showing 9,181 - 9,200 results of 34,553 for search '(( 50 ((ng decrease) OR (((we decrease) OR (a decrease)))) ) OR ( 5 point decrease ))', query time: 1.11s Refine Results
  1. 9181

    <i>cbp-1</i> RNAi inhibits DNA damage-induced excessive apoptosis in <i>prmt-5(gk357)</i> mutants. by Mei Yang (51996)

    Published 2009
    “…<p>(A) <i>cbp-1</i> RNAi performed in L4-stage animals decreases the mRNA level of <i>cbp-1</i>. Indicated animals at L4 stage were treated with <i>cbp-1</i> RNAi. …”
  2. 9182
  3. 9183
  4. 9184
  5. 9185
  6. 9186
  7. 9187
  8. 9188

    Image_1_Novel Action Targets of Natural Product Gliotoxin in Photosynthetic Apparatus.tif by Yanjing Guo (720645)

    Published 2020
    “…GT decreases the rate of oxygen evolution of PSII with an I<sub>50</sub> value of 60 µM. …”
  9. 9189

    Image_1_Novel Action Targets of Natural Product Gliotoxin in Photosynthetic Apparatus.tif by Yanjing Guo (720645)

    Published 2020
    “…GT decreases the rate of oxygen evolution of PSII with an I<sub>50</sub> value of 60 µM. …”
  10. 9190
  11. 9191
  12. 9192

    Changes in GF sound responses with age. by Jonathan M. Blagburn (8259648)

    Published 2020
    “…(C) Because the antennal sound sensitivity changes but the synapse strength remains constant, there is a corresponding decrease in sound sensitivity of the GF between 10 d and 30–50 d. …”
  13. 9193
  14. 9194
  15. 9195

    Response rate of patients with <i>CYP3A4</i> and <i>CYP3A5</i> polymorphisms after tacrolimus initiation. by Maizumi Furuse (10688237)

    Published 2021
    “…<p>Panel A shows the response rate of patients with <i>CYP3A4</i> polymorphisms at 1, 2, and 4 weeks after Tac treatment, and panel B shows that of patients with <i>CYP3A5</i> polymorphisms. Clinical response was defined as a partial Mayo score reduction of ≥2 points accompanied by a decrease of at least 30% from baseline and a decrease in the rectal bleeding subscore of ≥1 or an absolute rectal bleeding subscore of 0 or 1. …”
  16. 9196
  17. 9197

    IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and <i>in vivo</i> half-life: Potential application in combination with broad neutralizing antibodi... by Wenwen Bi (8086730)

    Published 2019
    “…To overcome this limitation, we developed a new strategy to extend the <i>in vivo</i> half-life of a short HIV-1 fusion inhibitory peptide, CP24, by fusing it with the human IgG Fc-binding peptide (IBP). …”
  18. 9198

    Early and late pulmonary effects of nebulized LPS in mice: An acute lung injury model by Natália de Souza Xavier Costa (4474648)

    Published 2017
    “…The LPS 5w group showed persistent lung inflammation, septal thickening, increased total lung volume, accentuated collagen deposition, especially of collagen type I, and decreased MMP-2 protein expression.…”
  19. 9199

    A Review of Surgical Ligation of Patent Ductus Arteriosus in a Neonate by Maxwell F. Kilcoyne (8693666)

    Published 2020
    “…<p>Introduction</p><p>As transcatheter technology improves, the need for surgical ligation of a patent ductus arteriosus (PDA) decreases. Until recently, no device was approved for infants <5 kg. …”
  20. 9200